The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AGI-134, a fully synthetic α-Gal-based cancer immunotherapy: Synergy with an anti-PD-1 antibody and pre-clinical pharmacokinetic and toxicity profiles.
 
Sascha A. Kristian
Employment - Agalimmune
Stock and Other Ownership Interests - Agalimmune
Research Funding - Kiadis Pharma (I)
Patents, Royalties, Other Intellectual Property - Kyowa Hakko Kirin
 
Stephen M. Shaw
Employment - Agalimmune
Stock and Other Ownership Interests - Agalimmune
 
Kim Wigglesworth
Honoraria - Agalimmune
Research Funding - Agalimmune
 
Jenny Middleton
Employment - Agalimmune
 
Melanie S. Glossop
Employment - Centauri Therapeutics
Honoraria - Agalimmune
Research Funding - Agalimmune
 
Giles Francis Whalen
No Relationships to Disclose
 
Robert Old
Stock and Other Ownership Interests - Premaitha health
Consulting or Advisory Role - Loxo
Patents, Royalties, Other Intellectual Property - Self
 
Uri Galili
Consulting or Advisory Role - Agalimmune
Patents, Royalties, Other Intellectual Property - University of Massachusetts Worcester
 
Mike Westby
Employment - Agalimmune
Leadership - Agalimmune
Stock and Other Ownership Interests - Agalimmune
Consulting or Advisory Role - Agalimmune
Travel, Accommodations, Expenses - Agalimmune
 
Chris Pickford
Employment - Agalimmune
Leadership - Agalimmune
Stock and Other Ownership Interests - Agalimmune
Consulting or Advisory Role - Agalimmune